The Risk of Dementia with the Use of 5 Alpha Reductase Inhibitors
June 2017
in “
Journal of the neurological sciences
”
Studysummary In this study, the use of 5 alpha reductase inhibitors was associated with an increased risk of dementia during the first two years of treatment, but the risk was not significant with longer exposure.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jns-journal.com →